摘要
目的:泛素参与细胞增殖和分化,本研究的目的是在兔PCO模型中通过腺病毒表达载体在预防中检测6位(K6W)的赖氨酸与色氨酸突变的显性负泛素(Ub)的后囊膜不透明(PCO)的潜力。 方法:用QBI-HEK 293A细胞产生具有绿色荧光蛋白(RAd-K6W-Ub / GFP)和RAd-GFP病毒(对照)的重组显性阴性K6W-Ub腺病毒(RAd-K6W-Ub) 接受镜片晶状体乳化术的新西兰兔子给予了术中前房内注射的病毒。运用裂隙灯生物显微镜拍摄的前段摄影图像通过后囊膜混浊人工软件(POCOman)进行PCO分级分析。用非接触眼压计(NCT)检测眼内压(IOP)。通过蛋白质印迹法检测α-平滑肌肌动蛋白(α-SMA)的表达。通过划痕愈合试验评估培养的兔子晶状体上皮细胞(LEC)中的细胞迁移能力。 结果:注射48小时后,镜片上皮中GFP和Ub的表达明显上调。 注射RAd-K6W-Ub的眼睛与对照组相比显示PCO程度明显降低。同时,RAd-K6W-Ub病毒剂量较高的组观察到较高的眼压和角膜水肿。与对照组相比,RAD-K6W-Ub眼中α-SMA的表达下调。细胞迁移被RAd-K6W-Ub抑制。 结论:适当剂量的RAD-K6W-Ub可以抑制兔子LECs的增殖和PCO的形成。 然而,较高剂量的Rad-K6W-Ub病毒载体对周围组织造成毒性作用,如角膜水肿和高IOP。
关键词: 后囊膜不透明(PCO),K6W-泛素,泛素 - 蛋白酶体途径(UPP),晶状体上皮细胞(LEC),腺病毒载体
Current Molecular Medicine
Title:Expression of Dominant Negative K6W-Ubiquitin in the Lens Epithelium via an Adenoviral Vector Delays Posterior Capsule Opacification in a Rabbit Model
Volume: 17 Issue: 2
关键词: 后囊膜不透明(PCO),K6W-泛素,泛素 - 蛋白酶体途径(UPP),晶状体上皮细胞(LEC),腺病毒载体
摘要: Purpose: Ubiquitin is involved in cell proliferation and differentiation, and the objective of this study is to investigate the potential of dominant negative Ubiquitin (Ub) with a lysine to tryptophan mutation at the 6 position (K6W) through an adenoviral expression vector in the prevention of posterior capsule opacification (PCO) in a rabbit PCO model.
Methods: Recombinant dominant negative K6W-Ub adenovirus (RAd-K6W-Ub) with green fluorescent protein (RAd-K6W-Ub/GFP) and RAd-GFP viruses (control) were generated with QBI-HEK 293A cells. New Zealand rabbits receiving lens phacoemulsification were given an intraoperative anterior chamber injection of the viruses. The images of anterior segment photography taken by a slit lamp biomicroscopy were analyzed by posterior capsule opacification manual software (POCOman) for PCO grading. The intraocular pressure (IOP) was detected with a non-contact tonometer (NCT). The expression of α-smooth muscle actin (α-SMA) was assessed by Western blotting. Cell migration ability in cultured rabbit’s lens epithelial cells (LECs) was evaluated by scratch healing assay. Results: The expression of GFP and Ub in the lens epithelium was markedly upregulated after 48 hours vector injection. Eyes injected with RAd-K6W-Ub showed a significantly lower PCO degree compared with controls. Meanwhile, higher IOP and corneal edema was observed in groups with a higher RAd-K6W-Ub virus dosage. The expression of α-SMA was down-regulated in the RAd-K6W-Ub eyes as compared to controls at the 15th day after injection. Cell migration was inhibited by RAd-K6W-Ub infection. Conclusions: RAd-K6W-Ub at an appropriate dosage could inhibit the proliferation of LECs and the formation of PCO in rabbit models. However, a higher dosage of Rad- K6W-Ub viral vector caused toxic effects to the surrounding tissues, such as corneal edema and high IOP.Export Options
About this article
Cite this article as:
Expression of Dominant Negative K6W-Ubiquitin in the Lens Epithelium via an Adenoviral Vector Delays Posterior Capsule Opacification in a Rabbit Model, Current Molecular Medicine 2017; 17 (2) . https://dx.doi.org/10.2174/1566524017666170331163751
DOI https://dx.doi.org/10.2174/1566524017666170331163751 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ultrasound-Induced Blood-Brain Barrier Opening
Current Pharmaceutical Biotechnology Targeting Transcription Factors in Acute Leukemia in Children
Current Drug Targets Peptides Targeting Gap Junctional Structures
Current Pharmaceutical Design Protein Kinases and Associated Pathways in Pluripotent State and Lineage Differentiation
Current Stem Cell Research & Therapy Melanogenesis Inhibitors: Strategies for Searching for and Evaluation of Active Compounds
Current Medicinal Chemistry Nuclear Architecture and Gene Expression in the Quest for Novel Therapeutics
Current Pharmaceutical Design Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery Cytosine Methyltransferases as Tumor Markers
Current Genomics Molecular Biology of Nucleoside Transporters and their Distributions and Functions in the Brain
Current Topics in Medicinal Chemistry Recent Patents on Rho Signaling Pathway as Therapeutic Target for Cardiovascular Diseases
Recent Patents on Cardiovascular Drug Discovery Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Aging as an Evolvability-Increasing Program Which can be Switched Off by Organism to Mobilize Additional Resources for Survival
Current Aging Science Structural Requirements for Efficient Phosphorylation of Nucleotide Analogs by Human Thymidylate Kinase
Mini-Reviews in Medicinal Chemistry Hemichannels in Cerebral Ischemia
Current Molecular Medicine Potential Beneficial Effects of Garlic in Oncohematology
Mini-Reviews in Medicinal Chemistry Small RNAs Play Big Roles: MicroRNAs in Diabetic Wound Healing
Current Molecular Medicine High-accuracy Automated Diagnosis of Parkinson's Disease
Current Medical Imaging The Role of Venous Abnormalities in Neurological Disease
Reviews on Recent Clinical Trials Gene Therapy in Liver Diseases: State-of-the-Art and Future Perspectives
Current Gene Therapy Stimuli-responsive Carriers for Controlled Intracellular Drug Release
Current Medicinal Chemistry